论文部分内容阅读
目的研究血栓通粉针字脑梗死患者中的应用,并分析其临床应用价值。方法 100例脑梗死患者,随机分为对照组和观察组,每组50例。对照组采用丹参粉针静脉滴注治疗,观察组采用血栓通粉针静脉滴注治疗。治疗2周后,对比两组治疗效果。结果观察组总有效率为86.0%,明显高于对照组的74.0%,差异有统计学意义(P<0.05)。治疗前,观察组神经功能缺损评分为(21.43±1.42)分,对照组为(20.37±1.16)分,比较差异无统计学意义(P>0.05)。治疗后,观察组神经功能缺损评分为(10.42±1.08)分,明显低于对照组的(15.07±1.19)分(P<0.05)。结论血栓通粉针在脑梗死患者治疗中具有较好的临床疗效,能有效改善患者的神经功能缺损症状,且无明显不良反应,值得在临床中推广应用。
Objective To study the application of thrombosis in patients with cerebral infarction and analyze its clinical value. Methods 100 patients with cerebral infarction were randomly divided into control group and observation group, 50 cases in each group. The control group was treated with intravenous infusion of Danshen powder injection and the observation group with intravenous infusion of thrombus through powder injection. After 2 weeks of treatment, the therapeutic effects of the two groups were compared. Results The total effective rate in observation group was 86.0%, which was significantly higher than that in control group (74.0%), the difference was statistically significant (P <0.05). Before treatment, the score of neurological deficit in observation group was (21.43 ± 1.42) points and that in control group was (20.37 ± 1.16) points, the difference was not statistically significant (P> 0.05). After treatment, the score of neurological deficit in the observation group was (10.42 ± 1.08) points, which was significantly lower than that in the control group (15.07 ± 1.19) points (P <0.05). Conclusion Thrombosis powder injection in the treatment of patients with cerebral infarction has a good clinical efficacy, can effectively improve the symptoms of patients with neurological deficits, and no significant adverse reactions, it is worth promoting in the clinical application.